Method for controlling self-immune disease relating to mhc using antagonistic substance to interferon gamma
专利汇可以提供Method for controlling self-immune disease relating to mhc using antagonistic substance to interferon gamma专利检索，专利查询，专利分析的服务。并且PURPOSE: To control diseases relating to MHC-relating immune response gene by dosing an interferon γ(IFN-γ)-antagonistic substance to a human body.
CONSTITUTION: An effective amount of an antagonist to IFN-γ (for example, an antibody to the cellular receptor of IFN-γ) which inhibits the physiological activity of IFN-γ by inhibition of linkage of IFN-γ to the cellular receptor, inhibition of synthesis of the cellular receptor or inhibition of synthesis of the cellular receptor by some mechanism, is dosed to control diseases relating the MHC-relating immune response gene. As such diseases, are cited systemic lupus erythematosus, myasthenica gravis, celiac disease, juvenile rheumatoid arthritis, Behcet's disease, pemphigus vulgaris, insulin dependent diabetes or autoimmune thyroiditis and it is given in the antibody concentration of 1-20mg/ml or in an amount of 0.1-2.0g/ml of blood of human body.
COPYRIGHT: (C)1989,JPO，下面是Method for controlling self-immune disease relating to mhc using antagonistic substance to interferon gamma专利的具体信息内容。
| 标题 | 发布/更新时间 | 阅读量 |
|---|---|---|
| 杂芳基SYK抑制剂 | 2020-05-12 | 210 |
| 针对外源抗原和/或自身抗原的免疫调控方法 | 2020-05-15 | 125 |
| 一类细胞坏死抑制剂及其制备方法和用途 | 2020-05-13 | 477 |
| 人小脑蛋白配体和包含其的双官能化合物 | 2020-05-14 | 420 |
| 抗PD-1抗体及其用途 | 2020-05-16 | 559 |
| 作为MAGL抑制剂的氨基甲酸1,1,1-三氟-3-羟基丙-2-基酯衍生物 | 2020-05-16 | 1061 |
| 人单克隆抗IL-32抗体、多核苷酸、载体、宿主细胞、制备方法、组合物及应用 | 2020-05-12 | 771 |
| 治疗或预防与肠通透性相关的病症的组合物和方法 | 2020-05-12 | 552 |
| γC细胞因子活性的稳定调节剂 | 2020-05-15 | 423 |
| 芳烃受体拮抗剂及其用途 | 2020-05-12 | 639 |
高效检索全球专利专利汇是专利免费检索,专利查询,专利分析-国家发明专利查询检索分析平台，是提供专利分析，专利查询，专利检索等数据服务功能的知识产权数据服务商。
我们的产品包含105个国家的1.26亿组数据，免费查、免费专利分析。
专利汇分析报告产品可以对行业情报数据进行梳理分析，涉及维度包括行业专利基本状况分析、地域分析、技术分析、发明人分析、申请人分析、专利权人分析、失效分析、核心专利分析、法律分析、研发重点分析、企业专利处境分析、技术处境分析、专利寿命分析、企业定位分析、引证分析等超过60个分析角度，系统通过AI智能系统对图表进行解读，只需1分钟，一键生成行业专利分析报告。
-
2 新治疗用途
